1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Mitchell Steiner

Discussion in 'GTX' started by Anonymous, May 26, 2014 at 11:24 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    He is now gone? Booted? Resigned?
    What other business interests....

  2. Anonymous

    Anonymous Guest

    The guy made millions each year - he never has to work again and still live in style: see link below

  3. Anonymous

    Anonymous Guest

    Little GTX, oh you're lookin' fine. Three deuces and a four speed, and a 389!